Search - tctmd.com

Displaying 1 - 20 of 34

Sort: Relevancy | Date

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Opinion CV Team Dispatch

July 2025 Dispatch for the CV Team

L.A. McKeown

July 24, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ACC 2024

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Yael L. Maxwell

April 09, 2024

News Conference News

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

Michael O'Riordan

March 22, 2024

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Conference News ACC 2022

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Michael O'Riordan

April 07, 2022

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT

Caitlin E. Cox

June 05, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2019

Shelley Wood

May 01, 2019

News Daily News

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

Michael O'Riordan

March 27, 2019

News Daily News

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

L.A. McKeown

March 21, 2019

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

Advertisement

August 2025 Dispatch for the CV Team

July 2025 Dispatch for the CV Team

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

September 2024 Dispatch for the CV Team

Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL

Intermittent Fasting Study Sparks Debate Over Increases in CV Mortality

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

February 2023 News Roundup

Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

TCTMD’s Top 10 Most Popular Stories for April 2019

Many Statin-Eligible Patients Don’t Take Meds, and Say Doctor Is to Blame

FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

TCTMD’s Top 10 Most Popular Stories for January 2019

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

TCTMD’s Top 10 Most Popular Stories for November 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content